Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Dividends Paid - Common (2016 - 2025)

Utah Medical Products has reported Dividends Paid - Common over the past 16 years, most recently at $977000.0 for Q4 2025.

  • Quarterly results put Dividends Paid - Common at $977000.0 for Q4 2025, down 5.88% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (down 6.5% YoY), and the annual figure for FY2025 was $4.0 million, down 6.5%.
  • Dividends Paid - Common for Q4 2025 was $977000.0 at Utah Medical Products, down from $988000.0 in the prior quarter.
  • Over the last five years, Dividends Paid - Common for UTMD hit a ceiling of $8.3 million in Q4 2021 and a floor of $977000.0 in Q4 2025.
  • Median Dividends Paid - Common over the past 5 years was $1.1 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Dividends Paid - Common: soared 719.33% in 2021 and later tumbled 87.41% in 2022.
  • Utah Medical Products' Dividends Paid - Common stood at $8.3 million in 2021, then plummeted by 87.41% to $1.1 million in 2022, then rose by 1.9% to $1.1 million in 2023, then dropped by 3.08% to $1.0 million in 2024, then decreased by 5.88% to $977000.0 in 2025.
  • The last three reported values for Dividends Paid - Common were $977000.0 (Q4 2025), $988000.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.